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Abstract— This work reviews the state-of-the-art neuromarkers 
development for the prognosis of Alzheimer’s diseases (AD) and 
mild cognitive impairment (MCI). The first part of this study is 
devoted to reviewing the recently emerged machine learning (ML) 
algorithms based on electroencephalography (EEG) and 
magnetoencephalography (MEG) modalities. In particular, the 
methods are categorized by different types of neuromarkers. The 
second part of the review is dedicated to a series of investigations 
that further highlight the differences between these two 
modalities. Firstly, several source reconstruction methods are 
reviewed and their source-level performances explored, followed 
by an objective comparison between EEG and MEG from multiple 
perspectives. Finally, a number of the most recent reports on 
classification of MCI/AD during resting state using EEG/MEG are 
documented to show the up-to-date performance for this well-
recognized data collecting scenario. It is noticed that the MEG 
modality may be particularly effective in distinguishing between 
subjects with MCI and healthy controls, a high classification 
accuracy of more than 98% was reported recently; whereas the 
EEG seems to be performing well in classifying AD and healthy 
subjects, which also reached around 98% of the accuracy. A 
number of influential factors have also been raised and suggested 
for careful considerations while evaluating the ML-based 
diagnosis systems in the real-world scenarios. 
 
Index Terms— Alzheimer's disease; mild cognitive impairment; 
MEG; EEG; biomarkers; neuromarkers. 
 
I. INTRODUCTION 
ITH the continuous development of health care 
provisions, the life expectancy of humans has witnessed 
an increasing trend in most of the world. Take UK for instance, 
during years 2014 to 2016, the life expectancy at birth was 79.2 
years for males and 82.9 years for females, which underwent a 
slight increment (one month for male and two weeks for female) 
compared to the year range 2013 to 2015 [1]. With the 
facilitation of better health care over the years, additional 
increase of the life expectancy can be expected from the 
developing countries. However, the expanded life expectancy 
also leads to a higher chance of getting the ageing-related brain 
disorders that can have devastating effects on our daily life, 
some of which are even the direct cause of death. Undoubtedly, 
as one of the most sophisticated organs of the human beings, 
brain is the least well-explored part of the body: the reasons 
behind many brain malfunctions are still not quite clear, even 
after centuries of research [2]. Dementia, particularly the 
Alzheimer’s disease (AD), is one of such brain malfunctions 
that can potentially lead to fatal consequences, if left without 
proper treatment in time. Over 9.9 million new cases of 
dementia are diagnosed each year worldwide, which implies 
one new case every 3.2 seconds. Of all the dementia cases, 
about 60%-70% are classified as AD [3]. Unfortunately, the 
cause of the AD is rather poorly understood, around 70% of the 
risks is believed to be genetic and many of which are related to 
genes directly [3, 4]. However, there are clear visual evidences 
observed in patients who have been diagnosed with AD: the 
size and shape of their brains tend to change drastically 
compared with the healthy brains [5]. It is therefore possible to 
detect and start the diagnosis process early, hence preventing or 
at least delaying the brain from evolving to the typical AD 
stage. As the prodromal/transitional process before AD, the 
confirmation of mild cognitive impairment (MCI) has become 
a critical factor to predict the occurrence of AD in the long run 
[6]. Although MCI is considered a pre-stage of AD and other 
dementias, the gradual cognitive decline may also be directly 
caused by other factors including depression, heart disease, 
diabetes, stroke, high blood pressure and cholesterol, or it may 
coexist with these comorbidities, as has been noted in [7]. For 
instance, it has been observed that the rate of conversion from 
MCI to AD can be 10% per year [8], which point to the 
importance of devising early neuro-rehabilitation and drug-
therapy programs to treat early symptoms. 
Moreover, with the age span increasing, there is an ever-
increasing demand for professional doctors with necessary 
expertise for MCI/AD treatment. This makes it a necessity to 
deploy a fast and potentially more affordable program for the 
diagnosis of MCI and early AD. With the rapid development in 
the Machine Learning (ML) field, in particular the 
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advancements in novel implementations for big data analysis 
[9, 10], a whole category of efficient and arguably more 
accurate ML approaches for the detection of early stage AD is 
now more viable than ever before. 
In recent years, several reports have emerged in the 
community using algorithms based on ML to discover 
biomarkers that are related to brain anatomical or functional 
characteristics, drug-treatment efficacy, disease mechanisms or 
general malfunctions of the brain. In a typical ML approach, 
usually features are explored to discover most critical diverging 
patterns among MCI/AD and healthy control subjects: the 
decision-making process of such classification/recognition only 
takes up a few seconds, which has therefore become one of the 
most appealing advantages over any human doctor. Another 
advantage of the ML approach is the efficiency of an expert 
system: given enough data, the system can be trained to learn 
incredible amount of information in a rather short period of time 
(the system training typically may take minutes to a few days 
maximum); whereas to train a qualified neurologist/clinician 
often needs years of hard working and internships. The ML-
supported program can potentially reduce the cost of diagnosis 
considerably. 
A number of clinical modalities have been developed to 
study dynamical changes of brain activity and also have 
demonstrated critical application for detecting and monitoring 
changes in brain disorders. These techniques can be routinely 
integrated into the ML framework. Among the frequently used 
neuroimaging modalities, electroencephalography (EEG) and 
magnetoencephalography (MEG) have been used to evaluate 
brain functional and connectivity changes in AD/MCI 
detections. A number of documented reviews/surveys have 
addressed the diagnosis of Alzheimer’s diseases and MCI using 
EEG/MEG from different angles. For example, the EEG and 
MEG based source connectivity analysis techniques focusing 
on AD were reviewed in [11]; using MEG as a putative 
biomarker for AD prediction/detection was reported in [12]; the 
MEG and its general analysis techniques are covered in [13]; a 
critical review specifically devoted to the EEG and ERP 
biomarkers of Alzheimer’s disease was proposed in [14]; one 
recent survey paper introduced various preclinical biomarkers 
for identifying AD and MCI based on EEG/MEG in detail from 
the medical/clinical perspective [15]. 
Biomarkers can be broadly categorized into two major types: 
pathophysiological and topographical markers. The indicators 
for brain amyloidosis and tautopathy, such as amyloid tracer 
PET scans, T-tau and P-tau, are considered pathophysiological, 
whereas these changes are accompanied by neuronal and 
synaptic atrophy, leading to brain metabolic and connectivity 
cascades that can be quantified using topographical markers 
such as DTI, fMRI, FDG-PET and M/EEG [16]. It is worth 
mentioning that for topographical markers, the M/EEG-based 
neuromarkers are good indicators for neurophysiological 
evaluation of the disease status and its progression process, 
however, they may not be quite effective for diagnostic 
purposes. Unlike the deposition of Amyloid-beta (Aβ) 1-42 or 
phosphorylated Tau in the brain, M/EEG-based topographical 
neuromarkers do not directly reflect the pathophysiological 
characteristics of MCI and AD in the brain [16]. This work aims 
to address the topic from a machine learning point of view, and 
particularly, reviews the recent studies mainly on the 
topographical neuromarkers that focus on EEG/MEG recorded 
in a resting state (RS) scenario. 
Several effective neuromarkers have been tested to predict 
the MCI and diagnose the AD [16, 17, 18, 19] . For example in 
the frequency domain, the power spectral density (PSD) and 
related methods have long been one of the most frequently used 
techniques to explore effective neuromarkers in EEG/MEG 
research [20, 21]. In the time domain, the analysis of functional 
connectivity has been especially useful in the study of unusual 
changes in region(s) of interest  and its communication [23]. 
For the RS M/EEG scenario, PSD-related neuromarkers are 
useful to study cortical synchronization/desynchronization, 
whereas the functional cortical/deep source connectivity is 
often evaluated by markers such as coherence, lagged linear 
connectivity and other indexes [16]. 
 Entropy is another popular statistical measure that have 
proven to be useful in neuromarkers research at the regional and 
functional connectivity level (e.g. Shannon spectral entropy 
[24], cross-approximate entropy [25] and dispersion entropy 
[26]). These methods are also often combined and implemented 
on top of other time-frequency analyses, such as the methods 
based on wavelet and empirical mode decomposition. 
The proposed neuromarkers in the literature critically rely on 
the underlying used modality. For instance, FDG-PET’s 
neuromarkers are associated with decrease/increase of 
metabolism in ROIs, possibly related to Alzheimer’s 
progression, whereas MRI is commonly used to measure brain 
atrophy, or more specifically atrophy in critical ROIs such as 
entorhinal and hippocampal areas due to its role in memory 
processes [27]. Similarly, fMRI can be used to study 
decreased/increased brain functional activity that may be 
related to changes in metabolism or atrophy. Independently, 
Tau-PET and Aβ PET’s neuromarkers can reveal those ROIs 
where tau and Aβ abnormal proteins accumulate with adverse 
effects such as synaptic and neuronal degeneration. Above 
modalities are excellent to identify affected ROIs due to its 
advantageous spatial properties, though they are much less 
relevant to study critical changes in brain oscillations.  
Due to its excellent temporal resolution and intrinsic 
properties, EEG/MEG are much better positioned to study the 
brain dynamical changes, and many techniques can be directly 
borrowed from other areas to study the neuronal 
communication phenomena, such as Hidden Markov Model 
from signal processing [28] and deep learning from artificial 
intelligence [29]. However, MEG arguably possess certain 
advantages over other modalities: Compared to EEG, 1) the 
helmet of the MEG machine usually contains large number of 
sensors (a typical MEG machine could have more than 300 
sensors), whereas EEG high density montages are limited to 
under 200 sensors with the burden of increased hours of 
preparation to reduce the electrodes impedance and guarantee 
the signal quality; 2) The magnetic field is mostly unaffected 
by the scalp which otherwise has negative filtering effects over 
the EEG signal; therefore source reconstruction analyses are 
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potentially more accurate for MEG data. As opposed to fMRI 
and PET, 3) MEG signals may offer real-time data analysis and 
monitoring of brain dynamical states, and thanks to the high 
density of the sensor montage, the reconstructed brain activity 
in the source space may achieve a spatial accuracy as good as 
that obtained with fMRI. In sum, MEG offers the highest 
temporal resolution, and therefore facilitates much richer 
statistical analysis that may exploit directly the critical 
information contained in neuronal oscillations. 
In this paper, we review the state-of-the-art neuromarkers for 
detecting/classifying the AD and MCI. It is subsequently 
organized into three main sections. Section II is devoted to the 
review of numerous neuromarkers in diagnosing the AD and 
MCI, which is further divided into four subsections for specific 
topics on different types of features. In Section III, we focus on 
addressing the problem from a comparative point of view. The 
M/EEG reported findings at sensor- and source-level analysis 
are firstly contrasted, followed by a systematic analysis of EEG 
and MEG results on MCI/AD classification, with particular 
interest in discussion of the most relevant results on resting state 
M/EEG for MCI/AD classification. Conclusions and discussion 
are presented in Section IV. 
II. NEUROMARKERS FOR MCI AND AD DETECTION 
The neuromarkers for MCI and AD detection/classification 
are reported in this section. Accurately diagnosing AD has been 
an active research topic for the past several decades; despite its 
vague cause, many effective neuromarkers were proposed in the 
literature to identify the presence of such brain mal-functioning. 
However, the development of the features within the machine 
learning scope is still underway, as the neuromarkers reported 
so far do not provide adequate specificity and sensitivity values 
for application in clinical practice. In addition, most of the 
reported neuromarkers are based on studies using a relatively 
small number of samples, and that critically affect the 
reproducibility of these studies. Even though in some reports, 
the cross-validation or other techniques only showed a small 
error, there is a risk of overfitting due to using the data obtained 
from small number of participants [28, 29]. The typical 
neuromarkers are discussed below under four broad categories. 
2.1 Time-domain neuromarkers 
One of the most intuitive ways for the neuromarker 
extraction is to find the informative features in the time domain 
directly. Mamani et al. [17] reported experiments using the 
grand average P450 event-related potential (ERP) as the feature 
for a three-class classification problem: 15 AD patients, 20 MCI 
subjects and 26 normal controls participated in the data 
collection experiments using a 32-channel EEG cap. Subjects 
were instructed to perform a series of visual-based working 
memory tasks. The independent component analysis was 
employed for automatic noise removal; the nonparametric 
Kruskal Wallis test is adopted to measure the cluster correction 
and 5% significance level were used to test the difference 
amongst the three classes; these classes were analysed using the 
conventional k-mean clustering algorithm. While performing 
the working memory tasks, it was found that the fronto-centro-
parietal electrodes captured the most distinctive ERP signals for 
the three-class classification. 
Yu et al. [20] proposed to use permutation dis-alignment 
index (PDI) to measure the coupling strength between EEG 
series in the time domain. Data from a 16-channel EEG system 
was collected to compute this feature; 14 right-handed patients 
with a diagnosis of AD and 14 age-matched healthy subjects 
participated in the experiment. Only the middle 10 minutes of 
recordings with high confidence were preserved for feature 
extraction; it was found that the value of PDI is inversely 
correlated with the strength of functional connectivity. Coupled 
with another neuromarker namely graph index complexity 
(GIC), the combined PDI-GIC neuromarker pair (weight ratio 
2:1) achieved classification rate of 98.9%, which improved by 
6.4% compared to using only the best single marker PDI. The 
recognition performance is quite encouraging; however, the 
number of subjects involved in the study is relatively low to 
generalize well across the AD population. 
2.2 Frequency domain neuromarkers 
As a complement to the time domain analysis, frequency 
analysis captures the features from the angle of maximising the 
energy/power information. With this approach, often the time 
information of the signal is entirely sacrificed. Therefore, often 
both the time and frequency domain features were extracted for 
better representation of the signal. Hornero et al. [32] presented 
a recognition system that could discriminate AD patients from 
healthy subjects by analysing the MEG background activities. 
A number of biomarkers were employed to test the 
effectiveness of classification, including the median frequency 
and spectral entropy in the frequency domain, approximate 
entropy and Lempel-Ziv complexity in the time domain. There 
were 41 elderly subjects involved in the experiment, 20 of 
which were AD patients and the rest were healthy controls. It is 
worth mentioning that the employed MEG system contained 
only 148 channels (comparable with some EEG systems); the 
signals were segmented into epochs of 10 seconds’ length. The 
linear discriminant analysis (LDA) and a forward stepwise 
LDA with a leave-one-out cross-validation scheme were used 
for feature selection and classification. The best classification 
rate was achieved using the spectral median frequency with an 
accuracy of 75.6%. By further sequentially combining the 
second-best feature, i.e. approximate entropy, the recognition 
accuracy increased to 80.5% (80.0% sensitivity, 81.0% 
specificity). The frequency domain power spectral density as 
the biomarker played a critical role in their experiment, and it 
appears that by combining frequency domain and time domain 
features, the system performance could receive a boost. 
Using EEG modality, power-based neuromarkers have also 
been used for MCI classification. Ye et al. [21] conducted a 
series of tasks to distinguish the healthy controls and MCI 
patients using a 64-channel EEG recording system. Their 
experiments included 22 participants, half of which were MCI 
subjects. The epoch length was 2.5 seconds during 
segmentation; the relative power ratio (the ratios are obtained 
by computing the individual band powers divided by the overall 
band power) was computed for each of these epochs. According 
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to their report, theta band is the main abnormal rhythm, whereas 
no significant differences were found between the relative alpha 
powers of two groups. It is also found that the MCI subjects in 
general have higher ratios and absolute power; in particular, the 
left temporal area was found as the most affected region in the 
brain for subjects with MCI. 
Mazaheri et al. [33] investigated the topic of whether the 
subtle anomalies in EEG activity of MCI patients during a word 
comprehension task could provide the evidence of the 
conversion to AD. The research involved 25 amnestic MCI 
patients, a subset of whom developed AD within 3-years, and 
the data from 11 elderly controls were used for the comparative 
analysis. The EEG data from 19 to 32 channels was recorded at 
250 Hz; time-frequency representations of power as the 
biomarkers were calculated for each trial (1 second prior to 
word onset, and 1.5 second after). It is well known that the 
sensor-level data analysis tends to be inaccurate due to the 
problems associated with volume conduction, i.e. the nearby 
electrodes pick up activities from the same sources hence make 
the received signals mixed. The method proposed in [33], 
instead of performing source reconstruction, attempted to 
circumvent this issue by focusing on trial-by-trial negative 
correlations [24, 33], given it is unlikely that a common source 
generates a simultaneous increase and decrease in power of 
different frequencies at distant electrode sites. They employed 
LDA and SVM to verify the hypothesis through classification 
performance. The best sensitivity and specificity of 80% and 
95% respectively were achieved by SVM. In addition, a d-
prime of 2.51 was reported to highlight the separation between 
the means of the signal and the noise distributions based on 
sensitivity index [36]. 
Poil et al. [37] proposed to combine multiple EEG-based 
neuromarkers into a diagnostic classification index; in this way 
the conversion from MCI to AD may be better predicted. In 
their work, the data from 86 patients were obtained; all of the 
subjects were initially diagnosed with MCI and during 2 years’ 
period, 25 patients of which converted to AD. Together 35 
different markers were extracted (including spatial, temporal 
and spectral features), six of which from both the temporal and 
spectral domains were selected for the prediction. The best 
single biomarker provided a sensitivity of 64% and specificity 
of 62%; by combining the six selected features, the 
performance was found increased to a sensitivity of 88% and 
specificity of 82%. Given the data was obtained from a 21-
channel system (much less raw information were captured 
compared with caps with high sensor density), these results 
indicated a clear advantage of employing multi-biomarker 
analysis in the clinical field. 
Recently, the cross-frequency coupling in cognition has 
become a new trend in neuromarker development. Dimitriadis 
et al. [38] investigated the phase coherence measure, in 
particular using the phase-to-amplitude estimator as a feature 
for the MCI vs. HC (healthy control) classification problem. 
Based on the EEG data captured from only a single sensor (Pz), 
a high recognition of 95% was achieved by using a poll of 
subjects containing 25 MCIs and 15 HCs. The data collection 
proceeded while subjects were performing the classic oddball 
tasks, with each trial of 1 second, in total 30 trials were obtained 
for each subject. Based on the leave-one-out cross-validation, 
their experimentations showed a high performance with 96% of 
sensitivity and 93% of the specificity. 
2.3 Entropy and Complexity 
Neuromarkers derived from the principle of entropy and 
complexity are found to be one of the most popular features for 
AD and MCI detection in the literature. Generally, researchers 
have been attempting to develop these kinds of neuromarkers 
broadly in two conventional ways: 1) entropy or entropy-related 
features computed using the time domain signals; 2) analysis of 
the complexity or entropy of the signals from the frequency 
domain perspective. The follow-up sub-sections are devoted to 
review a few of these researches from these two aspects. 
2.3.1 Time-domain analysis 
Gómez et al. [25] reported an accuracy of 70.83% (66.67% 
sensitivity, 75% specificity) using cross-approximate entropy 
to classify between AD patients and healthy controls. Cross-
approximate entropy is a measure of asynchrony between two 
paired time-series [39]; five minutes of data were recorded 
using a 148-channel MEG system and the cross-approximate 
entropy of the signal between channels were computed. In total 
24 subjects participated in the experiment, 12 of which were 
patients with AD and the rest were HCs. Compared with control 
subjects, a significantly higher synchrony was noticed between 
MEG signals from AD patients. 
Azami et al. [26] did another investigation on the 
effectiveness of using different entropies as neuromarkers for 
AD analysis. A 148-channel whole-head magnetometer system 
was employed to collect the MEG data from a pool of 62 
subjects, 36 of which were AD patients and the rest were the 
elderly controls. Four types of entropies, namely dispersion 
entropy (DisEn), fuzzy entropy, sample entropy (SampEn) and 
permutation entropy, were used to analyse the differences 
between the two classes. These features were directly computed 
in the time domain, using band-pass filtered signals (1.5-40 Hz) 
with segments of 10 seconds. The results indicated that the 
smallest p-value for AD patients vs. controls was obtained by 
using the DisEn; the computational efficiency of their newly 
proposed DisEn was also an appealing factor in the real-world 
scenario. 
Another relatively straightforward method for AD detection 
(and arguably related to [25]) is to directly measure the 
complexity of the brain signals in the time domain. Gómez et 
al. [40] proposed to compute the Lempel-Ziv complexity of the 
MEG signals, which were recorded for 5 minutes in a relaxed 
state with a 148-channel whole-head magnetometer. Data from 
10 patients with probable AD and 10 age-matched control 
subjects were used to test the effectiveness of the proposed 
biomarker, similar with the results reported in [39], it was found 
that the complexity level of the MEG signals from the AD class 
is significantly lower than the signals from the healthy controls. 
The problem on the classification of AD and HC has also 
been addressed through the regularity and complexity 
measurements of the background activities in [41]. In their 
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study, five minutes of data was obtained using a 148-channel 
MEG system, 20 patients with AD and 21 healthy subjects 
contributed their data for the experiments. By employing the 
SampEn and multiscale entropy as neuromarkers, the MEG 
recordings from AD patients were found less complex and more 
regular than that from the HC subjects. The accuracies of 75.6% 
with SampEn, and 87.8% with multiscale entropy were reached. 
2.3.2 Frequency-domain analysis 
Using the same database as in [41] (20 AD and 21 HC), Poza 
et al. [42] computed the entropy-based markers in the frequency 
domain. Firstly, the relative spectral powers of the segmented 
MEG signals were computed, then a series of features including 
Shannon spectral entropy, Tsallis spectral entropy, generalized 
escort-Tsallis spectral entropy and Rényi spectral entropy were 
computed, the optimal markers were selected based on the 
results of Mann-Whitney U test. The classification was done 
using a binary logistic regression. The results suggested a 
significant decrease in irregularity of AD patients’ MEG 
activity, which is in line with the observations that was reported 
in [41]. 
Entropy as a neuromarker can also be performed on top of 
other features for AD and MCI detections. For example, in [24], 
a series of entropies were computed to measure the classic 
frequency domain PSD. The objective was to classify between 
the MCI patients and the healthy controls using MEG data. 
Firstly, the PSDs from five typical brain regions were 
computed, these initial features were further used to compute 
Shannon spectral entropy, Tsallis spectral entropy and Rényi 
spectral entropy. Interestingly, in order to quantify the 
irregularity of MEGs, the Euclidean and the Wootters distances 
were employed as the disequilibrium measures. Using the data 
of a 10 seconds’ recording with subjects in a relaxed state, 
awake and with eyes closed, a highest recognition rate of 64.3% 
were achieved using the Shannon spectral entropy as the 
neuromarker. A total of 18 patients with MCI and 24 healthy 
subjects participated in this experiment ([24]), which is 
comparable with the report from [32] in terms of subject 
numbers and employed modality (both were using MEG data 
for analysis). The experimental results (80.5% vs. 64.3%) seem 
to verify that the classification between MCI and HC subjects 
are more challenging than AD vs. HC classification. 
Three-way classification of AD, MCI and HC subjects were 
also conducted by [43]. Data of 36 AD patients, 18 MCI 
subjects and 24 HC were recorded using a 148-channel whole-
head magnetometer. PSD was computed as the initial feature, 
then the Jensen’s divergence was adopted to measure the 
irregularity of the resulting PSDs. The results indicate 
significant changes of irregularity in the feature space for the 
data of AD patients, compared with MCI and heathy control 
subjects. The differences between MCI and HC are, however, 
less noticeable according to their report. These observations 
confirmed that the MCI is a transitional process towards AD 
stage from an ML point of view, and revealed that such 
classification is more challenging due to the prodromal nature 
of MCI. 
In order to improve the recognition performance, the attempt 
of combing the time-frequency domain features and entropy-
based neuromarkers were also made. Ruiz-Gómez et al. [44] 
tested a number of features, such as the relative power in the 
conventional frequency bands (i.e., delta, theta, alpha, beta, and 
gamma), median frequency, spectral entropy, sample entropy, 
and auto-mutual information. The experiments involved the 
classification for MCI, AD and HC. Each of the classes 
contained 37 subjects. Relevance and redundancy analyses 
were conducted to select the optimal set of features; LDA, 
quadratic discriminant analysis and multi-layer perceptron 
(MLP) were used to test and compare the classification 
performance. The results indicated MLP provided the highest 
performance for all the classification schemes: sensitivity of 
82.35% and positive predictive value of 84.85% for HC vs. all 
classification task; specificity of 79.41% and negative 
predictive value of 84.38% for AD vs. all comparison. 
Al-Nuaimi et al. [45] implemented a number of entropy and 
complexity based neuromarkers in the frequency domain. Data 
from 52 subjects were collected by a 19-channel EEG system, 
20 of which were AD patients and the rest were healthy 
controls. Three types of neuromarkers namely Tsallis entropy 
(TsEn), Higuchi Fractal Dimension (HFD), and Lempel-Ziv 
complexity (LZC) were computed using data from the 
frequency bands. The results showed that AD patients have 
significantly lower TsEn, HFD, and LZC values for specific 
EEG frequency bands. In particular, the LZC provided the best 
overall classification performance with a sensitivity of 100%, 
specificity of 92.31% and the recognition accuracy of 95%. It 
is well-recognized that the classification between AD and HC 
is relatively easier than distinguishing HC and MCI; authors of 
the work in [45] also pointed out this challenge as their future 
work. 
2.4 Other Neuromarkers 
As the prodromal stage towards AD, MCI is found quite 
challenging to diagnose. In [46], a transform namely complete 
ensemble empirical mode decomposition (CEEMD) was 
employed to extract the neuromarkers from non-stationary 
MEG signals. A nonlinear dynamics measure based on 
permutation entropy was used as the neuromarker, which 
measures the characteristics of the resulting intrinsic mode 
functions after CEEMD. The analysis of variance (ANOVA) 
was used to select the computed entropy features, followed by 
an enhanced probabilistic neural network for the classification 
between normal and abnormal subjects. The data was collected 
using a 148 sensors MEG system; 18 MCI and 19 normal 
subjects participated in the experiment. A considerably high 
accuracy of 98.4% was achieved using the enhanced 
probabilistic neural network classifier. This seems to suggest 
that besides the conventional approaches, some less traditional 
algorithms, which are especially developed for the non-
stationary signals can also be quite promising for AD/MCI 
detections. 
Blind source separation methods is another viable approach 
that have been used to improve the diagnosis of AD patients. 
Data from 18 AD patients and 18 HC subjects were used for 
extracting a range of features [47]: mean frequency, spectral 
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entropy, approximate entropy, and Lempel-Ziv complexity. 
From the separated signals, the features with the most 
significant inter-class differences and least correlated were 
preserved based on the results from the Student’s t-test. The 
preserved components were used to partially reconstructing the 
MEG channels, and the linear discriminant analysis was 
employed for classification. A significant boost in recognition 
rate from 72.2% to 80.6% was observed by performing the 
proposed blind source separation method. 
A method based on the positive and unseen learning 
algorithm was implemented by Rasheed et al. for the 
identification of mild traumatic brain injury (mTBI), which was 
considered principally similar with diagnosing MCI using 
default mode network analysis in [48]. In detail, the 
classification was performed by devising default coherence 
limits between all pairs of MEG sensors for positive (control) 
group (7 subjects), and the assessment of severity (15 subjects) 
was carried out by using the positive and unseen learning 
method (single class model). The classification outcome of the 
proposed algorithm was compared with the original diagnosis: 
the average similarity between the ground truth and the 
algorithm performance was 79.52%, while the minimum 
similarity was 73% and the maximum similarity was 91%. 
Another popular type of the biomarker is based on the 
cortical connectivity estimates. Gomez et al. [23] reported a 
diagnosis system to classify between MCI and HC subjects; 
data from 43 participants consisting of 18 MCI patients and 25 
elderly controls were involved in the experiment. A 148-
channel whole-head magnetometer (MAGNES 2500 WH, 4D 
Neuroimaging) was employed for the data collection, two 
connectivity measures, namely coherence and synchronization 
likelihood (SL) [49], were computed to measure the difference 
between the two classes. The results indicated that the 
coherence and SL mean values were lower in the MCI group 
than in control group at all frequency bands; it was also found 
the highest accuracy reached 69.8% in the beta band with both 
connectivity measures. 
Researchers have been trying to combine the information of 
different frequency bands of the brain signals in order to 
improve the classification performance. Yu et al. [50] proposed 
an MEG-based system for the classification between AD and 
HC. In total 27 patients with AD and 26 HC subjects 
participated in the data collection, the MEG data were recorded 
using a 306-channel whole-head system. Several multiplex hub 
and heterogeneity metrics were computed to capture both 
overall importance of each brain area and heterogeneity of the 
connectivity patterns across frequency-specific layers. Their 
work indicated that the proposed multiplex brain networks 
analysis contains important information that cannot be revealed 
only by using frequency-specific brain networks. It was also 
found that MEG-based resting state multiplex networks in 
Alzheimer’s disease were preferentially disrupted in hub 
regions, including regions in medial temporal lobe (left 
hippocampus), posterior default mode network and occipital 
regions. 
The MAGIC-AD multicentre initiative was recently created 
to advance AD research, which has already produced MEG 
datasets of significance value including one dataset with 78 
MCIs and 54 HCs in resting state, along with other two small 
datasets of 13 MCIs vs. 15 HCs and 11 MCIs vs. 13 HCs 
respectively, were employed [70]. In subsequent analysis by 
this group, the raw MEG signals were filtered into classic 
frequency bands (Theta (4-8Hz), Alpha (8-12 Hz), Beta (12-30 
Hz), Gamma (30-45 Hz) and broadband (2-45 Hz)). The mutual 
information was used as the feature to estimate functional 
connectivity between all pairs of magnetometers. A series of 
experimental schemes with different database combinations 
were investigated to test the robustness of the proposed feature. 
The best classification performance was 83% of the accuracy, 
with 100% sensitivity and 69% specificity. 
III. COMPARATIVE REVIEW 
The first part of this section is devoted to particularly 
reviewing the related source localization techniques on M/EEG; 
a number of factors on this technique that impact the 
classification are discussed. A comparative analysis of EEG and 
MEG in detecting AD and MCI is presented in the section 3.2, 
followed by a discussion on the pros and cons of these two 
modalities in the neurological field. Finally, a comparison of 
the recent works on MCI/AD/HC classifications in resting state 
is provided in section 3.3. 
3.1 M/EEG-based MCI/AD detection at source-level 
Despite numerous algorithms proposed for the source 
localization in literature, a great many challenges still remain: 
due to the ill-posed inverse problem, the selection of an 
appropriate inverse modelling algorithm becomes one of the 
most critical and debatable issues for the source-level analysis. 
Hincapié et al. [51] undertook a comparative analysis of some 
most popular source reconstruction methods, including the 
minimum norm estimate (MNE), linearly constrained minimum 
variance (LCMV) beamforming [52], and dynamic imaging of 
coherent sources (DICS) beamforming. A simulated sensor-
level data through forward modelling based on a 275 channel 
CTF MEG system [53] configuration was used for testing the 
effectiveness of the algorithms. The MNE assumes a Gaussian 
distribution for the noise which is uncorrelated with the brain 
activity; despite the debatable observations, the main 
assumption of beamformer methods is that the oscillatory 
activities are uncorrelated between two different sources or 
dipoles [54]. These assumptions may be unrealistic and may 
have impact on the selection of these algorithms in the real-
world scenarios. A few interesting observations were reported 
in [51]: though LCMV beamforming is a time-domain 
technique whereas the DICS beamforming works in the 
frequency domain, these two methods yielded similar 
performances in all the proposed test cases. Between the MNE 
and beamforming methods, it was found, for point-like sources 
(two coupled single-dipole sources), the spatial filters (LCMV 
and DICS) provided a better estimation of coherence, whereas 
MNE provided better coherence reconstructions when the 
simulated sources consisted of extended patches. These 
observations indicated the necessity of a scenario to imitate the 
real-life applications before deciding which source localization 
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method to use. 
Another important factor for solving MEG/EEG inverse 
problems is the use of a template image or an individual MRI 
image for source reconstruction. A recent study conducted by 
Douw et al. [55] investigated the topic using data from 17 
healthy participants who provided their MEG and MRI scans 
during a resting state recording with eyes closed. Relative 
power from six typical frequency bands for each region of 
interest after averaging were used as the neuromarkers. 
Functional connectivity (phase lag index) between each pair of 
regions was also calculated. It was found that there was no 
(systematic) bias or inconsistency between the results for the 
template and native MRI implementations, which is an 
important result in the field. 
The combination of MEG and other modalities for feature 
extraction demonstrated good performance. Nakamura et al. 
[56] investigated the prodromal stages of AD based on MEG 
modality. A linearly constrained minimum variance 
beamforming technique was employed to perform the source 
reconstruction. MEG data obtained from 28 individuals with 
mild cognitive impairment and 38 cognitively normal 
individuals were used for feature extraction. The preliminary 
feature extracted was the regional spectral patterns, and then the 
integrating information from Pittsburgh compound B-PET, 
fluorodeoxyglucose-PET, structural MRI, and cognitive tests 
were analysed. The results demonstrated that regional spectral 
patterns of resting state activity could be separated into several 
types of MEG signatures [56], which may be used as useful 
biomarkers for the pre-dementia stages of Alzheimer’s disease. 
Usage of the source localization algorithm on EEG for the 
diagnosis of early AD was studied by Aghajani et al. [57]. Data 
obtained from 17 HC subjects and 17 subjects with AD were 
used for the data analysis. The source localization method was 
the standardized low-resolution brain electromagnetic 
tomography (sLORETA), the relative logarithmic power 
spectral density values from four conventional EEG bands 
(alpha, beta, delta, and theta) were extracted from 12 selected 
cortical regions. The results showed that the right temporal 
region reflected a significant difference between the two groups 
in all frequency bands; in the left brain hemisphere the theta 
band power increased whereas the alpha band decreased for AD 
patients. The classification performances using a support vector 
machine between AD and HC groups were accuracy of 84.4%, 
sensitivity 75.0%, and specificity of 93.7%. 
Dimitriadis et al. [58] recently proposed a source-level 
analysis based on the reconstructed MEG signals. It 
investigated the performance of different analytic strategies of 
single-layer and multi-layer representations of functional brain 
networks. Three connectivity estimators namely phase locking 
value (PLV), the imaginary part of PLV (iPLV) and the 
correlation of the envelope (CorrEnv) were computed and used 
as the neuromarkers. Four minutes of resting state activity were 
obtained using a 306-channel Elekta Vectorview system from 
24 MCI patients and 30 healthy controls. The source 
reconstruction was performed using an LCMV beamformer. 
Particularly, following the Yu et al.’s research [50], Dimitriadis 
et. al. [58] also proposed studying the intra and cross-frequency 
coupling or functional connectivity estimators as novel 
neuromarkers. They reported a highest classification accuracy 
of 98% using the CorrEnv feature. Despite the remarkable 
performance, the authors also pointed out the importance of 
testing the performance in a second blind cohort; due to the non-
stationary characteristics of the time-series, using cross-
validation within one database often tend to yield biased 
performance. 
A recent investigation showed that the brain networks tend 
to facilitate information propagation across different 
frequencies, which was demonstrated by the analysis of multi-
participation coefficients (MPC) [59]. In this work, the PSDs 
were used as features for the classification problem of AD vs. 
HC; each class contained the data obtained from 25 subjects. 
The data was collected using a whole-head MEG system with 
102 magnetometers and 204 planar gradiometers (Elekta 
Neuromag TRIUX MEG system). To solve the inverse 
problem, a weighted Minimum Norm Estimate algorithm with 
overlapping spheres was employed. It was found that the 
regional connectivity in AD subjects abnormally distributed 
across frequency bands as compared to controls, causing 
significant decreases of MPC, which was similar with the trend 
found in the entropy-based analysis results. The best 
classification accuracy of 78.39% was reported for the proposed 
detection system. 
Medvedeva and Yahno [60] reported an investigation based 
on using the EEG signals for the analysis of AD and MCI. Data 
from 131 AD, 45 MCI and 45 HC subjects were collected using 
a digital 19-channel scalp EEG device based on the 
International 10-20 system [61]. For each subject, 40 seconds 
of artefact-free EEG recording was kept and segmented into a 
window size of 2 seconds. Coherence measurements were 
computed and used as the biomarkers, combined with the 
eLORETA for the source-level analysis. Statistically 
significant differences between AD and MCI patients for theta 
band coherences were found. In addition, MCI subjects showed 
reduced coherence compared with healthy controls in certain 
regions. 
Babiloni et al. [62] investigated the individual alpha 
frequency peak (IAF) and transition frequency (TF) after 
conventional FFT-based power spectral analysis, as features for 
the classification between MCIs and HCs. A 19-sensor EEG 
cap was used to capture the raw signals; eight bands (delta, 
theta, alpha 1, alpha 2, alpha 3, beta 1, beta 2, and gamma), and 
five ROIs (frontal, central, parietal, occipital, and temporal) 
were taken into the consideration during the data analysis. A 
source reconstruction method namely eLORETA was used to 
estimate the functional lagged linear connectivity solutions. It 
was reported that the best recognition performance for MCI vs. 
HC were sensitivity of 73% and specificity of 64%, led an 
accuracy of 68.5% and an area under ROC curve of 0.71. 
An interesting investigation was conducted by Pineda-Pardo 
et al. [63] on the classification of the HC, single-domain MCI 
and multiple-domain MCI subjects. According to the report, 
Single-domain MCI (sdMCI) showed isolated memory 
impairment, whereas multiple-domain MCI (mdMCI) showed 
memory deficit accompanied by various degrees of impairment 
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in cognitive domains such as executive functions, visual- spatial 
skills, and/or language. A 306-channel MEG system was 
employed for data collection, a database containing 29 HCs, 22 
sdMCIs and 30 mdMCIs in resting state were used for this 
classification problem; an atlas-based anatomical parcellation 
of 66 regions was obtained for each subject. A minimum 
variance beamformer algorithm was adopted for the source 
reconstruction. The reconstructed time-domain connectivity 
matrix was directly used as features for classification. A 
number of classifiers, namely k-NN, LDA, SVM with different 
kernels were selected for distinguishing the three classes. The 
best accuracies were as follows: HC vs sdMCI 86.27%, HC vs 
mdMCI 81.36% and sdMCI vs mdMCI 84.62%. 
Some recent works on the classification between MCI/AD 
and HC in the source-level are illustrated in Table 1. It appears: 
1) different type of source reconstruction methods do not yield 
significant difference in performance if the database size is 
comparable; 2) while the number of subjects increases, the 
recognition performance tends to degrade drastically (98% 
compare to less than 70%). Here the modality information is 
purposely ignored, as it is hard to make a fair judgement given 
that very limited results are reported to date. In the next section, 
a further comparison is made to address the effectiveness of 
EEG and MEG on MCI/AD detection. 
3.2 EEG vs. MEG: A comparative analysis 
EEG as an electrophysiological brain monitoring approach 
has almost 100 years of usage history: the first human EEG 
recording was obtained by Hans Berger in 1924 [64]; since then 
EEG has been implemented in a series of different scenarios [64， 
65，66]. As one of the non-intrusive modalities, EEG not only 
benefits from its relatively easy deployment, but also it is 
considerably cheaper than MEG in equipment purchasing and 
maintenance. It is therefore popular among researchers for 
quantitative analysis of brain activations. 
On the other hand, MEG received increasing attentions in 
recent years despite the need of high financial investment to 
prepare the related equipment for data collection and analysis. 
One of the major advantages of the MEG over EEG is that the 
magnetic fields are less distorted than the electric fields by the 
skull and scalp, which results in a better spatiotemporal 
resolution compared with EEG. High spatial resolution used to 
be an appealing advantage of image-based modality such as 
fMRI, but nowadays we can also reach a comparable quality of 
spatial resolution using MEG. Not least important, the 
preparation time for participants in the MEG system is much 
less than in EEG system (a few minutes vs. roughly one hour), 
which have a critical effect on the disposition of the participants 
and hence the data quality. A brief comparative analysis 
between EEG and MEG based on the state-of-the-art literature 
in relation to the AD and MCI detection is outlined below.  
 Table 2 and Table 3 illustrate some of the most recent 
research outcomes, separately for studies using EEG or MEG 
modality. For the sake of clarity and straightforward 
comparison, only the classification accuracy is reported here. It 
is noticed that classification accuracies are similar between 
analyses using these techniques, though slightly better results 
seem to be obtained using MEG modality particularly for HC 
vs. MCI scenario. We attribute the latter to the high density of 
MEG sensor arrays in contrast to EEG, and the simpler relation 
between neuronal activities generated inside the brain and 
externally collected signals. Otherwise, we observed that the 
classification between AD and HC has been found to provide 
better performance than the MCI vs. HC for both M/EEG, but 
this observation may be difficult to corroborate as there are only 
few studies simultaneously analysing all these 3 categories. As 
MCI is considered a prodromal stage of AD, it would be 
Table 2. Comparison between two classification scenarios using EEG 
EEG-based Report Accuracies MCI vs. HC AD vs. HC 
Poil et al., 2013 [37] 85%  
Aghajani et al., 2013 [57]  84.4% 
Al-Nuaimi et al., 2016 [45]  96% 
Mazaheri et al., 2017 [33] 87.5%  
Ruiz-Gómez et al., 2018 [44]  82% 
Yu et al., 2018 [20]  98.9% 
 
Table 1. Some reports on MCI/AD detection using source reconstruction techniques 
Modality Neuromarkers Source Reconstruction Subjects Classification Accuracy 
MEG Regional spectral patterns, integrating 
information from Pittsburgh compound B-PET, 
fluorodeoxyglucose-PET, structural MRI, and 
cognitive tests [56] 
Minimum variance 
beamforming 
28 MCI, 38 HC 
Within HC to predict amyloid-β 
positivity: 76.3% 
Within MCI to predict amyloid-β 
positivity: 78.6% 
EEG Relative logarithmic power spectral density 
values [57] 
sLORETA 17 AD, 17 HC 84.4% 
MEG 
Phase locking value (PLV), the imaginary part of 




24 MCI, 30 HC 
98% for the correlation of the 
envelope and 94% for the 
imaginary part of PLV 
MEG PSD [59] Weighted Minimum Norm 
Estimate 
25 AD, 25 HC 78.39% 
EEG coherence measurements  [60] eLORETA 131 AD, 45 
MCI, 45 HC 
N/A 
EEG Individual alpha frequency peak, 
Transition frequency [62] 
eLORETA 75 MCI, 
75 HC 
68.5% 
MEG time domain connectivity matrix [63] Minimum variance 
beamformer 
22 sd MCIs, 30 
md MCIs, 29 
HC vs. sdMCI 86.27% 
HC vs. mdMCI 81.36% 
sdMCI vs mdMCI 84.62% 
 
0018-9294 (c) 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TBME.2019.2898871, IEEE
Transactions on Biomedical Engineering
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
9 
interesting to study: 1) which neuromarkers appear consistently 
in both AD vs. HC and MCI vs. HC analyses, as well as which 
ones are less stable. 2) regarding the individual neuromarker 
trends, whether these tend to show ceiling effects, further 
deteriorate or show less impact in AD as compared to MCI, 
when considering HC as a baseline state. The results in Table 3 
seem to suggest that the MEG have a great potential in detecting 
early signs of AD; a few rather high accuracies were reported 
in this recognition scenario. This evidence seems to indicate 
that MEG may be more appropriate for studying MCI, AD and 
other dementias when compared to EEG, though it may be 
obscured due to the fact MEG has been only recently used for 
this purpose.  
 It is also needed to objectively pointing out that the correct 
design of data analysis approaches is paramount to obtaining 
significant and reproducible results. For example in [58], the 
highest performance was 98%, which was obtained through a 
5-fold cross-validation, whereas a performance of around 75% 
was also reported in the same study for the same data but using 
leave-one-out cross-validation, while using the same strategy of 
feature selection in both analysis. Due to the dramatic 
differences, we recommend to be cautious when interpreting 
such results and appreciations. In general, there are negative 
impacts and liabilities in using a relative small number of 
samples in these studies [28, 29]. Therefore, it is important for 
the M/EEG community to share their databases to ensure better 
reproducibility and enhanced statistical power by allowing 
multi-site statistical testing and data combination.  
In addition, by further analysing the Table 3, a recent 
research by Amesquita-Sanchez et al. [46] proved to be quite 
promising. Different from the conventional biomarkers which 
derived from Fourier-based time-frequency analysis, the 
entropy-based biomarker employed in this work was built on 
top of empirical mode decomposition [68], a specially designed 
transform for non-stationary time-series. It is also noticed that 
in comparison to the performance of MCI detections, usage of 
MEG for AD detection still needs more investigations. Given 
the availability of mass AD databases in hospitals, a 
considerable boost to the research can be expected if more 
researchers will share/release the databases to the community. 
3.3 Resting state comparison 
In this section, we propose to compare some recent M/EEG 
system performances documented in the literature, while 
subjects remained in a resting state condition [69]. The resting 
state is one of the most common experimental scenarios and 
Table 4. Resting state using EEG for MCI/AD detection, the sequence of the report is stacked downward based on the year of publication till the most recent 
Feature(s) Subjects Channels Recording Epoch length Performance 
Relative logarithmic power spectral 
density values [57] 
17 AD, 17 
HC 
128 3-4 minutes N/A Maximum accuracy 84.4% 
Cross-frequency coupling measurements 
[38] 
(This is VEP task) 
25 MCI, 15 
HC 
Pz 2 types of 
recordings 
each last for 30 
seconds 
1 second Maximum accuracy 95% 
Band power [21] 11 MCI, 11 
HC 
64 60 seconds 2.5 seconds Theta relative power of MCI is 
larger than HC 
Relative power in the conventional 
frequency bands, median frequency, 
individual alpha frequency, spectral 
entropy, Lempel-Ziv complexity, central 
tendency measure, sample entropy, fuzzy 
entropy, and auto-mutual information [44] 
37 AD, 37 
MCI, 37 
HC 
19 5 minutes 5 seconds Maximum accuracy HC vs. All: 
78.43% 
Maximum accuracy AD vs. All: 
76.47% 
Permutation dis-alignment index [20] 14 AD, 14 
HC 
16 10 minutes 8 seconds Maximum accuracy 92.5% 
Tsallis entropy, Higuchi Fractal 
Dimension, and Lempel-Ziv complexity 
[45] 
32 AD, 20 
HC 
19 3 minutes 3 minutes Maximum accuracy for single 
channel 85% 
FFT-based power spectrum analysis, 
individual alpha frequency peak, 





19 5 minutes 2 seconds Accuracy 63.48% ± 7.06% 
Coherence measurements [60] 131 AD, 45 
MCI, 45 
HC 
19 40 seconds 2 seconds N/A 
 
Table 3. Comparison between two classification scenarios using MEG 
MEG-based Report Accuracies MCI vs. HC AD vs. HC 
Escudero et al., 2007 [47]  80.6% 
Gómez et al., 2007 [41]  87.8% 
Poza et al., 2007 [42]  85.4% 
Hornero et al., 2008 [32]  80.5% 
Bruna et al., 2010 [24] 64.3%  
Gómez et al., 2012 [25]  70.83% 
Sanchez et al., 2016 [46] 98.4%  
Guillon et al., 2017 [59]  78.39% 
Rasheed et al., 2017 [48] 79.52%  
Hernandez et al., 2018 [23] 69.8%  
Nakamura et al., 2018 [56] 78.6%  
Dimitriadis et al., 2018 [58] 98%  
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assumed as least affected by individual cognitive processes. 
The system performances reported based on this scenario are 
arguably comparable. Depending on the modalities (MEG and 
EEG), the most recent papers are listed in Table 4 and Table 5, 
respectively. 
Table 4 lists a few recent papers reporting on MCI/AD 
detections using EEG data obtained in resting state. It is found 
that the power and entropy features are often considered as 
effective neuromarkers in detecting MCI and/or AD. Only a 
few minutes of recording appears to be enough for analysis, 
which is something worth pointing out. Usually in the clinical 
scenarios, there are ample recording length available. For MEG 
modality (Table 5), the entropy and complexity features are 
rather prevalent, whereas the power-based neuromarker appears 
to be less popular compared with EEG. The overall 
performance obtained using MEG for MCI/AD detection seems 
to be relatively worse than that of using EEG. A few 
suggestions can be made for better experiment design:  
1) It seems most of the results are based on data obtained from 
single recording session, in contrast to longitudinal studies; 
such a scenario makes it quite difficult to address the issue of 
individual differences and expected changes associated with 
healthy ageing. Therefore, we suggest that research in MCI/AD 
changes should be combined with research in healthy ageing 
processes. 
2) The recording length for each session should not 
necessarily be too long (a few minutes is found to be enough) 
in order to guarantee the quality of the features that capture the 
studied phenomena. Additionally, as AD affects multiple 
cognitive areas of the brain, diverse cognitive stimulation 
paradigms should be combined to better explore the cognitive 
changes. 
3) Currently, the results are still incongruent, which can be 
attributed to the relatively small samples used in Alzheimer’s 
research but also the disease heterogeneity, together with the 
wide range of used methodologies. For example, using the same 
database and features, the performances obtained through 
Table 5 Resting state using MEG for MCI/AD detection, the sequence of the reports is stacked downward based on the year of publication till the most recent. 
Feature(s) Subjects Channels Recording Epoch length Performance 
Lempel-Ziv complexity [40] 10 AD, 10 
HC 
148 5 minutes 20 seconds ADs have less LZ complexity 
Mean frequency, spectral entropy, 
approximate entropy, and Lempel-
Ziv complexity [47] 
18 AD, 18 
HC 
148 5 minutes 20 seconds Without blind source separation 
(BSS): 72.2% of accuracy 
With BSS: 80.6% of accuracy 
Shannon spectral entropy, Tsallis 
spectral entropy, generalized escort-
Tsallis spectral entropy and Rényi 
spectral entropy, calculated from the 
relative spectral power [42] 
20 AD, 21 
HC 
148 5 minutes 10 seconds Maximum accuracy 85.4% 
Sample entropy and multiscale 
entropy [41] 
20 AD, 21 
HC 
148 5 minutes 10 seconds Maximum accuracy 87.8% 
Median frequency, spectral entropy, 
approximate entropy, Lempel-Ziv 
complexity [32] 
20 AD, 21 
HC 
148 5 minutes 10 seconds Maximum accuracy 80.5% 




148 5 minutes 24 seconds Maximum accuracy 69.8% 
Shannon spectral entropy, Tsallis 
spectral entropy, and Rényi spectral 
entropy (RSE), based on the 




148 5 minutes 10 seconds Maximum accuracy of is 64.3% 
obtained from Shannon spectral 
entropy 
Cross-approximate entropy [25] 12 AD, 12 
HC 
148 5 minutes 5 seconds Maximum accuracy 70.83% 
Disequilibrium: PSD-based Jensen’s 
divergence [43] 
36 AD, 18 
MCI, 24 
HC 
148 5 minutes 5 seconds AD significantly different from 
MCI; MCI slightly different from 
HC. 





306 3 minutes 10 seconds Maximum accuracy 86.27% 




2 seconds Maximum accuracy 83% 
Dispersion entropy [26] 36 AD, 26 
HC 
148 5 minutes 10 seconds p-value ranges from 0.006 to 0.114 
Amyloid-beta deposition on regional 
power spectra [56] 
28 MCI, 
38 HC 
306 5 minutes 10 seconds N/A 
Phase locking value, imaginary part 




306 4 minutes 10 seconds Maximum accuracy 98% for 5-
fold cross-validation; 75% for 






0018-9294 (c) 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TBME.2019.2898871, IEEE
Transactions on Biomedical Engineering
> REPLACE THIS LINE WITH YOUR PAPER IDENTIFICATION NUMBER (DOUBLE-CLICK HERE TO EDIT) < 
 
11 
leave-one-out cross validation and n-fold cross validation have 
resulted in a change of  more than 20% of accuracy [58]. In a 
real-life clinical scenario, current MCI/AD/HC classification 
accuracies are still not found sufficiently high as needed in 
clinical applications [58]. We exhort researchers to increase the 
sample size of ongoing studies and to share EEG/MEG database 
to openly comparing the developed methodologies. 
IV. DISCUSSION AND CONCLUSION 
This work explored the state-of-the-art neuromarkers from 
the ML perspective; its primary aim has been to review the 
mainstream algorithms devised for detecting/predicting MCI 
and AD using MEG and/or EEG signals. It is found that overall 
the MEG tends to perform slightly worse than EEG. However, 
as a relatively new modality, MEG has shown great potential in 
the field, particularly for MCI detection [46]. EEG with its 
much lower cost has been used for diagnosing the brain diseases 
for much longer time than MEG; the properties of the EEG 
signal are much well-studied and better understood. In general, 
there appears to be huge variability in prediction performance 
reported in the literature by algorithms using both EEG and 
MEG modalities. There is an urgent need to arrive at a 
consensus in terms of a single neuromarker or a neuromarkers 
combination most suitable for application in clinical practice. 
Given its minor deployment in general, much work could be 
done in excavating the potential of MEG in MCI/AD detection. 
From the perspective of information gain, MEG modality 
intuitively should be much more informative than EEG signals, 
due to its higher sensor density and arguably more information 
per channel. Another strategy to boost the prediction 
performance is to combine the EEG and MEG: a multi-modal 
recognition system equipped with a well-designed fusion 
algorithm can synergistically combine complementary 
information from both modalities. From a broad perspective, 
using M/EEG based machine learning algorithms to classify 
AD patients and patients with other neurodegenerative diseases 
(such as Parkinson’s disease, Lewy body dementia) may also 
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